Roberts Pharmaceutical
This article was originally published in The Tan Sheet
Executive Summary
Signs "two-step" agreement to acquire line of 21 Rx and OTC drugs from Glaxo Canada. The first part of the deal, which covers products purchased outright, includes five OTCs: Betnesol topical anti-inflammatory steroid, Prenavite prenatal vitamin supplement, bacitracin zinc ointment, Glaxal moisturizing cream and Barriere hand cream. Under part two of the deal, Roberts will market and promote certain Glaxo products in Canada including the Rx antihypertensive Trandate, the OTC dermatological Betnovate, and Dequadin OTC throat lozenges. Eatontown, N.J.-based Roberts said it has the option to purchase these products "subject to certain conditions".